Interactive Case: Choosing and Using CDK4/6 Inhibitors in Breast Cancer - First-line Therapy
The approvals of palbociclib and ribociclib, the first cyclin-dependent kinase 4 and 6 (CDK4/6) inhibitors, provided advanced or metastatic hormone-positive, human epidermal growth factor receptor 2-n...
Author: imedex
Added: 10/02/2017 (Source: Oncology Tube)
Source: Oncology Tube - October 2, 2017 Category: Cancer & Oncology Source Type: podcasts
Interactive Case: Choosing and Using CDK4/6 Inhibitors for Breast Cancer - Second-line Therapy
The approvals of palbociclib and ribociclib, the first cyclin-dependent kinase 4 and 6 (CDK4/6) inhibitors, provided advanced or metastatic hormone-positive, human epidermal growth factor receptor 2-n...
Author: imedex
Added: 10/02/2017 (Source: Oncology Tube)
Source: Oncology Tube - October 2, 2017 Category: Cancer & Oncology Source Type: podcasts
Sep 15 Cardiology News
PFO closure for recurrent stroke prevention, hormone replacement in women, DAPT, obesity, and fentanyl are discussed in this week ' s podcast. (Source: Medscape Cardiology Podcast)
Source: Medscape Cardiology Podcast - September 15, 2017 Category: Cardiology Authors: Medscape Source Type: podcasts
PodMed – Week of September 18, 2017
This week’s topics include hospital factors relative to readmission, hormone therapy, lymph node dissection in breast cancer, and the cost of bringing a new drug to market. Program notes: 0:32 Cost of R and D versus profit in new drugs 1:32 Took 7.3 years 2:35 Reaping in sales far outstrips R and D 3:32 R […] (Source: Johns Hopkins Medicine Weekly Health News)
Source: Johns Hopkins Medicine Weekly Health News - September 15, 2017 Category: Consumer Health News Authors: Elizabeth Tracey Johns Hopkins Medicine Tags: All Podcasts Breast Health Cancer Patient Care PodMed Source Type: podcasts
Menopausal Hormone Therapy and Long-term All-Cause and Cause-Specific Mortality
Interview with JoAnn E. Manson, MD, DrPH, author of Menopausal Hormone Therapy and Long-Term All-Cause and Cause-Specific Mortality: The Women’s Health Initiative Randomized Trials (Source: JAMA Author Interviews)
Source: JAMA Author Interviews - September 12, 2017 Category: General Medicine Authors: The JAMA Network Source Type: podcasts
NAMS' New Hormone Therapy Position Statement: Clinical Takeaways
Who can safely take hormone therapy and for how long? Are there alternatives? Dr JoAnn Manson answers questions based on the new position statement from the North American Menopause Society. (Source: Medscape Medscape Podcast)
Source: Medscape Medscape Podcast - August 15, 2017 Category: General Medicine Authors: Medscape Source Type: podcasts
NAMS' Hormone Therapy Statement: Primary Care Takeaways
Who can safely take hormone therapy and for how long? Are there alternatives? Dr JoAnn Manson answers questions based on the new position statement from the North American Menopause Society. (Source: Medscape ObGyn Podcast)
Source: Medscape ObGyn Podcast - August 15, 2017 Category: OBGYN Authors: Medscape Source Type: podcasts
What to Know About the NAMS Updated Position on Hormone Therapy
Systemic HT is an appropriate choice for symptomatic women in their 50s or within 10 years of the onset of menopause, Dr Kaunitz says. (Source: Medscape ObGyn Podcast)
Source: Medscape ObGyn Podcast - July 17, 2017 Category: OBGYN Authors: Medscape Source Type: podcasts
What to Know About the NAMS Updated Position on Hormone Therapy
Systemic HT is an appropriate choice for symptomatic women in their 50s or within 10 years of the onset of menopause, Dr Kaunitz says. (Source: Medscape Medscape Podcast)
Source: Medscape Medscape Podcast - July 17, 2017 Category: General Medicine Authors: Medscape Source Type: podcasts
How should hormone-sensitive advanced prostate cancer be treated?
Nancy Dawson, MD of Lombardi Cancer Center at Georgetown University Hospital discusses how physicians should treat hormone-sensitive advanced prostate cancer patients. This was recorded at the 2017 AS...
Author: obr
Added: 06/20/2017 (Source: Oncology Tube)
Source: Oncology Tube - June 20, 2017 Category: Cancer & Oncology Source Type: podcasts
